Search Results - Lawhorn, Kristie

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Effects of glutamine for prevention of radiation-induced esophagitis: a double-blind placebo-controlled trial

    Effects of glutamine for prevention of radiation-induced esophagitis: a double-blind placebo-controlled trial by Alshawa, Anas, Cadena, Alexandra Perez, Stephen, Bettzy, Reddy, Akhila, Mendoza, Tito R., McQuinn, Lacey, Lawhorn, Kristie, Zarifa, Abdulrazzak, Bernhardt, Alexander Maximilian, Fessaheye, Senait, Warneke, Carla L., Chang, Joe Y., Naing, Aung

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Targeting hypoxia-inducible factor-1α (HIF-1α) in combination with antiangiogenic therapy: a phase I trial of bortezomib plus bevacizumab

    Targeting hypoxia-inducible factor-1α (HIF-1α) in combination with antiangiogenic therapy: a phase I trial of bortezomib plus bevacizumab by Falchook, Gerald S, Wheler, Jennifer J, Naing, Aung, Jackson, Edward F, Janku, Filip, Hong, David, Ng, Chaan S, Tannir, Nizar M, Lawhorn, Kristie N, Huang, Mei, Angelo, Laura S, Vishwamitra, Deeksha, Hess, Kenneth, Howard, Adrienne N, Parkhurst, Kristin L, Amin, Hesham M, Kurzrock, Razelle

    Published in Oncotarget
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Epidermal Growth Factor Receptor-targeted Therapy with C225 and Cisplatin in Patients with Head and Neck Cancer

    Epidermal Growth Factor Receptor-targeted Therapy with C225 and Cisplatin in Patients with Head and Neck Cancer by SHIN, Dong M, DONATO, Nicholas J, CLAYMAN, Gary, PFISTER, David, FALCEY, John, WAKSAL, Harlan, MENDELSOHN, John, WAUN KI HONG, PEREZ-SOLER, Roman, SHIN, Hyung Ju C, WU, Ji Y, ZHANG, Peter, LAWHORN, Kristie, KHURI, Fadlo R, GLISSON, Bonnie S, MYERS, Jeffrey

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neck

    Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neck by Tseng, Jennifer E., Glisson, Bonnie S., Khuri, Fadlo R., Shin, Dong M., Myers, Jeffrey N., El‐Naggar, Adel K., Roach, Jennifer S., Ginsberg, Lawrence E., Thall, Peter F., Wang, Xuemei, Teddy, Stephanie, Lawhorn, Kristie N., Zentgraf, Rebecca E., Steinhaus, Ganene D., Pluda, James M., Abbruzzese, James L., Hong, Waun Ki, Herbst, Roy S.

    Published in Cancer
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  5. 5
    The Prevalence and Impact of Hyperglycemia and Hyperlipidemia in Patients With Advanced Cancer Receiving Combination Treatment With the Mammalian Target of Rapamycin Inhibitor Temsirolimus and Insulin Growth Factor‐Receptor Antibody Cixutumumab

    The Prevalence and Impact of Hyperglycemia and Hyperlipidemia in Patients With Advanced Cancer Receiving Combination Treatment With the Mammalian Target of Rapamycin Inhibitor Tems... by Busaidy, Naifa L., LoRusso, Patricia, Lawhorn, Kristie, Hess, Kenneth R., Habra, Mohammed Amir, Fu, Siqing, Hong, David S., Chen, Helen X., Doyle, Lawrence A., Kurzrock, Razelle, Naing, Aung

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    PEG-Intron for Myeloproliferative Diseases: An Update of Ongoing Phase II Study

    PEG-Intron for Myeloproliferative Diseases: An Update of Ongoing Phase II Study by Verstovsek, Srdan, Lawhorn, Kristie, Giles, Francis, Cortes, Jorge, Thomas, Deborah, Garcia-Manero, Guillermo, Ferrajoli, Alessandra, Faderl, Stefan, Beran, Miloslav, Talpaz, Moshe, Kantarjian, Hagop

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: